Does Industry Really Develop Less Medicines With Clinical Benefit?

To the Editor We read with interest the study by Osipenko et al exploring the association between the perceived clinical benefit of medicines and their origins, whether they come from academia, industry, or cross-sector collaborations. We commend the authors for their transparency in sharing the data used for analysis.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research